Genmab — November 2020
-
God morgen.

-
God morgen

-
Sanofi offers to acquire Kiadis for €308 million https://www.globenewswire.com/news-release/2020/11/02/2118112/0/en/Sanofi-offers-to-acquire-Kiadis-for-308-million.html#.X5-2yMRvny4.twitter
-
275% præmie!
-
Lommepenge for Sanofi, men...
-
-
Monoclonal Antibodies to Treat Multiple Myeloma: https://www.mdpi.com/1422-0067/21/21/8192/htm
-
-- TEPEZZA (teprotumumab-trbw) Third-Quarter 2020 Net Sales of $286.9 Million; Increasing Full-Year 2020 Guidance to Greater Than $800 Million from Greater Than $650 Million; Significantly Increasing Investment in TEPEZZA to Support Continued Strong Growth --
-
Pursuing TEPEZZA Expansion Outside the United States -- https://ir.horizontherapeutics.com/news-releases/news-release-details/horizon-therapeutics-plc-reports-record-third-quarter-2020
-
the Dara- Duobodies combo-trial adds pomalidomide https://clinicaltrials.gov/ct2/history/NCT04108195?A=12&B=13&C=merged#StudyPageTop
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind